000 01331 a2200373 4500
005 20250515232357.0
264 0 _c20100802
008 201008s 0 0 eng d
022 _a1749-6632
024 7 _a10.1111/j.1749-6632.2010.05512.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAtlasz, T
245 0 0 _aPituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects.
_h[electronic resource]
260 _bAnnals of the New York Academy of Sciences
_cJul 2010
300 _a128-39 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aHumans
650 0 4 _aPituitary Adenylate Cyclase-Activating Polypeptide
_xmetabolism
650 0 4 _aRats
650 0 4 _aReceptors, Pituitary Adenylate Cyclase-Activating Polypeptide
_xmetabolism
650 0 4 _aRetina
_xmetabolism
700 1 _aSzabadfi, K
700 1 _aKiss, P
700 1 _aRacz, B
700 1 _aGallyas, F
700 1 _aTamas, A
700 1 _aGaal, V
700 1 _aMarton, Zs
700 1 _aGabriel, R
700 1 _aReglodi, D
773 0 _tAnnals of the New York Academy of Sciences
_gvol. 1200
_gp. 128-39
856 4 0 _uhttps://doi.org/10.1111/j.1749-6632.2010.05512.x
_zAvailable from publisher's website
999 _c19975817
_d19975817